CSat Investment Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$900K Buy
3,618
+3,598
+17,990% +$859K 0.76% 51
2020
Q4
$5K Sell
20
-2,887
-99% -$666K ﹤0.01% 474
2020
Q3
$739K Buy
2,907
+309
+12% +$76.6K 0.07% 138
2020
Q2
$612K Buy
2,598
+63
+2% +$14.4K 0.07% 148
2020
Q1
$514K Buy
2,535
+959
+61% +$209K 0.11% 133
2019
Q4
$380K Buy
1,576
+478
+44% +$105K 0.1% 180
2019
Q3
$212K Buy
1,098
+117
+12% +$22.5K 0.07% 200
2019
Q2
$181K Buy
981
+967
+6,907% +$173K 0.06% 203
2019
Q1
$3K Buy
14
+2
+17% +$382 ﹤0.01% 523
2018
Q4
$2K Buy
12
+3
+33% +$585 ﹤0.01% 525
2018
Q3
$2K Buy
9
+2
+29% +$394 ﹤0.01% 519
2018
Q2
$1K Buy
+7
New +$1.24K ﹤0.01% 541

Other funds holding AMGN

CSat Investment Advisory's AMGN Position: Q1 2021 in Review

CSat Investment Advisory increased its Amgen (AMGN) stake by 17,990% in Q1 2021, buying an estimated $859K and bringing the position to 3,618 shares worth $900K. The position accounts for 0.76% of the portfolio, ranked #51.

CSat Investment Advisory first reported a position in AMGN in Q2 2018 and has held it in 12 quarters since. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • CSat Investment Advisory held 3,618 shares of Amgen worth $900K as of Q1 2021.
  • CSat Investment Advisory bought 3,598 Amgen shares in Q1 2021, an estimated $859K.
  • Amgen made up 0.76% of CSat Investment Advisory's portfolio in Q1 2021, its #51 holding.
  • CSat Investment Advisory first reported a position in Amgen in Q2 2018 and has held it in 12 quarters since.
  • 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.